Section 144-283-1 - PURPOSEA. This rule implements 22 MRS §§ 1532, 1533 and 22-A MRS §210 which require the Department of Health and Human Services (Department) to (1) establish a bloodspot screening program for newborns to detect certain congenital genetic disorders which, if left untreated, can cause intellectual and developmental disability, serious illness or death, and (2) establish a statewide genetics program; and (3) authorize the Department to assess fees upon healthcare providers to cover the costs of bloodspot screening. This rule requires the responsible hospital, birthing center, physician, midwife, principal birthing attendant, or other healthcare provider to ensure NBS specimens are taken from each infant either born in the State of Maine or residing in Maine within three months of birth, unless the infant's parent(s) object on religious grounds. 10-144 C.M.R. ch. 283, § 1